12
Participants
Start Date
September 30, 2010
Primary Completion Date
October 31, 2010
Study Completion Date
October 31, 2010
CX157
CX157 Modified Release Tablet 125 mg administered twice per day on study days 4-11 and in the morning of study day 12.
Placebo
Placebo administered twice per day on study days 4-11 and in the morning of day 12.
Comprehensive Phase One, Miramar
Lead Sponsor
CeNeRx BioPharma Inc.
INDUSTRY